Gala Pharmaceutical Inc. Operating Lease, Expense
Gala Pharmaceutical Inc. reported Operating Lease, Expense of $19.05 thousand for the 3-month period ending 2019-05-31, per its 10-Q filed 2019-07-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2019-07-23
- Gala Pharmaceutical Inc. operating lease, expense for the quarter ending 2019-05-31 was $19.05K, a 82.86% increase year-over-year.
- Gala Pharmaceutical Inc. operating lease, expense for the quarter ending 2019-02-28 was $28.05K, a 112.74% increase year-over-year.
- Gala Pharmaceutical Inc. operating lease, expense for the quarter ending 2018-11-30 was $48.50K, a 232.51% increase year-over-year.
- Gala Pharmaceutical Inc. operating lease, expense for the quarter ending 2018-08-31 was $9.70K, a 823.81% increase year-over-year.
- Gala Pharmaceutical Inc. operating lease, expense for fiscal 2018 was $81.80K, a 352.30% increase from fiscal 2017.
- Gala Pharmaceutical Inc. operating lease, expense for fiscal 2017 was $18.09K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2019-05-31 | $19.05K 10-Q · filed 2019-07-23 | $47.10K 10-Q · filed 2019-07-23 | $95.60K derived: sum of 3 quarters · filed 2019-07-23 | $105.30K derived: sum of 4 quarters · filed 2019-07-23 |
| 2019-02-28 | $28.05K 10-Q · filed 2019-04-30 | $76.55K derived: sum of 2 quarters · filed 2019-04-30 | $86.25K derived: sum of 3 quarters · filed 2019-04-30 | $96.66K derived: sum of 4 quarters · filed 2019-07-23 |
| 2018-11-30 | $48.50K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-15 | $58.20K derived: sum of 2 quarters · filed 2019-04-15 | $68.61K derived: sum of 3 quarters · filed 2019-07-23 | $81.80K 10-K · filed 2019-04-15 |
| 2018-08-31 | $9.70K 10-Q · filed 2018-10-26 | $20.12K derived: sum of 2 quarters · filed 2019-07-23 | $33.30K 10-Q · filed 2018-10-26 | $47.89K derived: sum of 4 quarters · filed 2019-07-23 |
| 2018-05-31 | $10.42K 10-Q · filed 2019-07-23 | $23.60K 10-Q · filed 2019-07-23 | $38.19K derived: sum of 3 quarters · filed 2019-07-23 | $39.24K derived: sum of 4 quarters · filed 2019-07-23 |
| 2018-02-28 | $13.19K 10-Q · filed 2019-04-30 | $27.77K derived: sum of 2 quarters · filed 2019-04-30 | $28.82K derived: sum of 3 quarters · filed 2019-04-30 | $30.22K derived: sum of 4 quarters · filed 2019-04-30 |
| 2017-11-30 | $14.59K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-15 | $15.63K derived: sum of 2 quarters · filed 2019-04-15 | $17.04K derived: sum of 3 quarters · filed 2019-04-15 | $18.09K 10-K · filed 2019-04-15 |
| 2017-08-31 | $1.05K 10-Q · filed 2018-10-26 | $2.45K derived: sum of 2 quarters · filed 2018-10-26 | $3.50K 10-Q · filed 2018-10-26 | |
| 2017-05-31 | $1.40K 10-Q · filed 2018-08-01 | $2.45K 10-Q · filed 2018-08-01 | ||
| 2017-02-28 | $1.05K 10-Q · filed 2018-05-08 |